Galapagos | GLPG - Cost Of Sales

Stock Price
28.42
Daily Change
0.10 0.35%
Monthly
-0.63%
Yearly
13.77%
Q1 Forecast
27.85

Galapagos reported EUR84.73M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
argenx SE USD 149.69M 40.26M Dec/2025
AstraZeneca USD 3.27B 471M Dec/2025
Biogen USD 810.1M 205.1M Sep/2025
Genmab DKK 57M 15M Jun/2025
Gilead Sciences USD 1.62B 50M Dec/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
GRIFOLS EUR 1.13B 15.63M Sep/2025
Hikma Pharmaceutical USD 466.5M 428.5M Jun/2025
Incyte USD 121.18M 22.18M Dec/2025
Merck EUR 2.1B 123M Sep/2025
Neurocrine Biosciences USD 17.6M 246.4M Dec/2025
Novartis USD 3.54B 217M Sep/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 4.29B 421M Dec/2025
UCB EUR 901M 50M Dec/2024
Vertex Pharmaceuticals USD 466M 51.2M Dec/2025